|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-2-6
|
|
pubmed:abstractText |
We studied the influence of biochemical and virologic patterns and interferon on the outcome of anti-HBe positive chronic hepatitis B in 164 (103 treated) consecutive patients, followed-up prospectively for a mean of 6 years (21 months-12 years).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
263-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11830339-Adolescent,
pubmed-meshheading:11830339-Adult,
pubmed-meshheading:11830339-Age Distribution,
pubmed-meshheading:11830339-Aged,
pubmed-meshheading:11830339-Antiviral Agents,
pubmed-meshheading:11830339-DNA, Viral,
pubmed-meshheading:11830339-Female,
pubmed-meshheading:11830339-Follow-Up Studies,
pubmed-meshheading:11830339-Hepatitis B, Chronic,
pubmed-meshheading:11830339-Hepatitis B e Antigens,
pubmed-meshheading:11830339-Hepatitis B virus,
pubmed-meshheading:11830339-Humans,
pubmed-meshheading:11830339-Interferon-alpha,
pubmed-meshheading:11830339-Liver Cirrhosis,
pubmed-meshheading:11830339-Male,
pubmed-meshheading:11830339-Middle Aged,
pubmed-meshheading:11830339-Multivariate Analysis,
pubmed-meshheading:11830339-Prospective Studies,
pubmed-meshheading:11830339-Treatment Outcome,
pubmed-meshheading:11830339-Virus Replication
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study.
|
|
pubmed:affiliation |
U.O. Gastroenterologia ed Epatologia, Spedali Riuniti di Santa Chiara, Via Paradisa n. 2 - Cisanello, 56124 Pisa, Italy. brunetto@med-club.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
